Literature DB >> 8490387

Screening for prostatic cancer.

R H Harwood.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8490387      PMCID： PMC1677286          DOI： 10.1136/bmj.306.6881.855

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Total androgen ablation: Canadian experience.

Authors:  G Béland; M Elhilali; Y Fradet; B Laroche; E W Ramsey; J Trachtenberg; P M Venner; H D Tewari
Journal:  Urol Clin North Am       Date:  1991-02       Impact factor: 2.241

2.  Prostate cancer: to screen or not to screen?

Authors:  F H Schröder
Journal:  BMJ       Date:  1993-02-13

3.  Radical surgery versus radiotherapy for adenocarcinoma of the prostate.

Authors:  D F Paulson; G H Lin; W Hinshaw; S Stephani
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

4.  Radical surgery for prostatic cancer.

Authors:  P C Walsh; H J Jewett
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

5.  Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up.

Authors:  P H Graversen; K T Nielsen; T C Gasser; D K Corle; P O Madsen
Journal:  Urology       Date:  1990-12       Impact factor: 2.649

6.  A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

Authors:  E D Crawford; M A Eisenberger; D G McLeod; J T Spaulding; R Benson; F A Dorr; B A Blumenstein; M A Davis; P J Goodman
Journal:  N Engl J Med       Date:  1989-08-17       Impact factor: 91.245

7.  Natural history of localised prostatic cancer. A population-based study in 223 untreated patients.

Authors:  J E Johansson; H O Adami; S O Andersson; R Bergström; U B Krusemo; W Kraaz
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

8.  Total androgen ablation: European experience. The EORTC GU Group.

Authors:  L Denis; P Smith; J L Carneiro de Moura; D Newling; A Bono; F Keuppens; C Mahler; M Robinson; R Sylvester; M De Pauw
Journal:  Urol Clin North Am       Date:  1991-02       Impact factor: 2.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.